Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Ketamine and Propofol NeuroImaging
Keith M Vogt
A Study Comparing Effectiveness of Kesimpta® (Ofatumumab) Versus Ocrevus® (Ocrelizumab) in Real-world Practice
Novartis Pharmaceuticals
Safety and Tolerability Trial of Psilocybin in Healthy Older Adults
University of Colorado, Denver
Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine
University of Pennsylvania
Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer
Gustavo Vazquez
Ketamine Assisted Psychotherapy for Treating Comorbid Chronic Pain and PTSD
Dr. Yuliya Knyahnytska
Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants
University Hospital, Basel, Switzerland
ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
Salma Health, Inc.
Anesthesia Management in Endovascular Therapy for Ischemic Stroke - 2
University Hospital, Clermont-Ferrand
Psilocybin for Prolonged Grief Disorder
University of Virginia
Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants
University Hospital, Basel, Switzerland
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
University of Virginia
Pharmacokinetics of Didehydro-LSD (DDH-LSD) Compared With LSD
University Hospital, Basel, Switzerland
Prospective IR-led Sedation Feasibility
CAMC Health System
Ketamine for Veterans With Parkinson's Disease
VA Office of Research and Development
The Role of Coadministration of Lidocaine and Ketamine in Opioid-Refractory Chronic Cancer-Related Pain.
National and Kapodistrian University of Athens
MDMA-Assisted Therapy for Mental Healthcare Providers
Rachel Yehuda
Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability
Johns Hopkins University
Ketamine for Opioid Use Disorder
University of Maryland, Baltimore
Ecstasy to Alleviate SEvere Chronic Neuropathic Pain Trial
Unity Health Toronto
Psilocybin Microdose for Psychological and Existential Distress in Palliative Care (PSYCHED-PAL-RCT)
Bruyère Health Research Institute.
LSD Treatment for Persons With Alcohol Use Disorder
Felix Mueller
Pilot Study of RR-HNK in OCD
Carolyn Rodriguez
Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved.
The Ketamine Research Foundation
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
Janssen Research & Development, LLC
RCT of Psilocybin-assisted CBT for Depression
University of California, Los Angeles
Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer
Alan Davis
Psilocybin on Brain Mechanisms of Motivation in OUD
University of Pennsylvania
Psilocybin for Opioid Use Disorder (OUD)
NYU Langone Health
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Cybin IRL Limited
Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression
VA Office of Research and Development
A Phase 2A Trial of DT402 for Autism Spectrum Disorder
Definium Therapeutics US, Inc.
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
ACADIA Pharmaceuticals Inc.
Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients
Texas Tech University Health Sciences Center
Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects
Medical University of Vienna
Investigating the Persisting Effects of a Single Dose of Psilocybin on Structural Plasticity in Healthy Older Adults
University of California, Berkeley
Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication
University of British Columbia
Wellcome Leap Psilocybin for OUD
Anna Rose Childress, Ph.D.
PsiloIMAGINE: A Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm
Imperial College London
Supra Inguinal Fascia Iliaca Block as Rescue Analgesia Following Total Hip Arthroplasty
Institut Mutualiste Montsouris
Virtual Reality-Based Mindfulness as an Adjunct to Treatment as Usual in Treatment-Resistant Depression
Hospital Universitari Vall d'Hebron Research Institute
Psilocybin and Methylenedioxymethamphetamine (MDMA) for Post-traumatic Stress Disorder (PTSD)
Johns Hopkins University
Anesthesia Techniques, Neuroprotection and Surgical Field in FESS Under Controlled Hypotension
University General Hospital of Patras
MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)
Carolyn Rodriguez
Mapping Ibogaine Neural Dynamics in Opioid Use Disorder
University of California, Irvine
MDMA in Borderline Personality Disorder
Yale University
Analgosedation With Ketamine, Nalbuphine, or Dexmedetomidine for Suture Removal in Children After Cleft Surgery
University Medical Centre Ljubljana
Pain Control Alternatives in Pediatric Patients With Distal Radius Fractures
State University of New York at Buffalo
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.